RxDoctor Payments Data

Anne Stover, MD

Family Medicine · Boardman, OHNPI 1174516835

Payments from drug & device makers

$453in general payments, 2019–2025

Across 27 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$117
  • Novo Nordisk$86
  • Merck$46
  • Amarin Pharma, Inc.$42
  • Pfizer$30
  • E.r. Squibb & Sons, L.L.C.$29
  • plus $103 from 6 others

What the payments were for

  • Food & beverage$453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$453 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$48,245
Medicare patients
134
Services billed
638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban117$111,143
JardianceEmpagliflozin111$87,697
RybelsusSemaglutide56$68,163
OzempicSemaglutide49$58,812
JanuviaSitagliptin Phosphate53$51,677
TrulicityDulaglutide40$46,222
MounjaroTirzepatide27$29,430
XareltoRivaroxaban38$23,703
ProliaDenosumab13$22,462
FarxigaDapagliflozin Propanediol17$15,786
Synjardy XrEmpagliflozin/Metformin Hcl12$14,671
VascepaIcosapent Ethyl19$13,868
Combivent RespimatIpratropium/Albuterol Sulfate24$11,201
MyrbetriqMirabegron22$10,262
Varenicline Tartrate29$8,734

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$86$126,975105 claims
Boehringer IngelheimJardiance, Synjardy Xr, Combivent Respimat$13$113,569147 claims
PfizerEliquis$30$111,143117 claims
Lilly USA, LLCTrulicity, Mounjaro$18$75,65267 claims
MerckJanuvia$46$51,67753 claims
AbbVieLinzess, Synthroid$117$11,55881 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Boardman

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →